Cargando…
CD8A as a Prognostic and Immunotherapy Predictive Biomarker Can Be Evaluated by MRI Radiomics Features in Bladder Cancer
SIMPLE SUMMARY: It is necessary to explore a reliable predictive biomarker for immunotherapeutic strategies in bladder cancer. As an important member of tumor-infiltrating immune cells, cytotoxic T cells are the ultimate effectors of cancer rejection because of their specificity against cancer cells...
Autores principales: | Zheng, Zongtai, Guo, Yadong, Huang, Xiongsheng, Liu, Ji, Wang, Ruiliang, Qiu, Xiaofu, Liu, Shenghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564077/ https://www.ncbi.nlm.nih.gov/pubmed/36230788 http://dx.doi.org/10.3390/cancers14194866 |
Ejemplares similares
-
Development of a Molecular-Subtype-Associated Immune Prognostic Signature That Can Be Recognized by MRI Radiomics Features in Bladder Cancer
por: Liu, Shenghua, et al.
Publicado: (2023) -
Combining Multiparametric MRI Radiomics Signature With the Vesical Imaging-Reporting and Data System (VI-RADS) Score to Preoperatively Differentiate Muscle Invasion of Bladder Cancer
por: Zheng, Zongtai, et al.
Publicado: (2021) -
Construction and Validation of a Novel Eight-Gene Risk Signature to Predict the Progression and Prognosis of Bladder Cancer
por: Wang, Ruiliang, et al.
Publicado: (2021) -
Magnetic resonance imaging-based radiomics signature for preoperative prediction of Ki67 expression in bladder cancer
por: Zheng, Zongtai, et al.
Publicado: (2021) -
Association between radiomics features of DCE-MRI and CD8(+) and CD4(+) TILs in advanced gastric cancer
por: Huang, Huizhen, et al.
Publicado: (2023)